Brevan Howard Capital Management LP
Position in WGS — GeneDx Holdings Corp.
CIK 1512857
ST. HELIER, Y9
Position in WGS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,934,007
+$1,570,137 QoQ
Shares Held
28,172
+397.2% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#87
of 223 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in WGS Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Brevan Howard Capital Management LP holds $50,602,015 across 19 Diagnostics & Research names. WGS ranks #10 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
35,098 | $9,527,351 | |
| 2 | DHR |
Danaher Corp /De/
|
31,646 | $6,027,930 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
11,225 | $5,627,766 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
10,606 | $5,583,422 | |
| 5 | DGX |
Quest Diagnostics Inc
|
15,507 | $3,286,708 | |
| 6 | GH |
Guardant Health, Inc.
|
19,677 | $2,952,139 | |
| 7 | LH |
Labcorp Holdings Inc.
|
8,660 | $2,424,800 | |
| 8 | ILMN |
Illumina, Inc.
|
12,643 | $2,223,018 |
All Filings in WGS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,934,007 | 28,172 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $363,870 | 5,666 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $329,832 | 2,536 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $560,248 | 5,200 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||